11 July 2024
ECO Animal Health Group plc
("ECO" or the "Company")
Notice of Results
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it will issue its financial results for the year ended 31 March 2024 on 15 July 2024.
Investor Presentation
David Hallas, CEO, and Christopher Wilks, CFO, will host a virtual briefing and Q&A session for analysts at 11:00 BST on the day of results.
For further information about the analyst presentation, please contact ecoanimalhealth@consilium-comms.com.
-Ends-
For further information please contact:
|
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com